Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Clinical trial NCT00003926 · TERMINATED

Trial details

NCT number: NCT00003926
Sponsor: Masonic Cancer Center, University of Minnesota
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Childhood Germ Cell Tumor Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma

Start date: 1998-11-01
Primary completion: 2002-08-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.